Vaxil Bio's total assets for Q3 2024 were C$820.00K, a decrease of -4.98% from the previous quarter. TSE:VXL total liabilities were C$82.00K for the fiscal quarter, a 7.89% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.